Intellectual Property India Publishes Patent Application for 3d Droplet-Based Bioprinted Gelma-Liposomal Pentoxyfilline Constructs For In Vitro Studies

MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202641115707 A) filed by Vellore Institute Of Technology on September 28, 2026, for 3d Droplet-Based Bioprinted Gelma-Liposomal Pentoxyfilline Constructs For In Vitro Studies.

Inventors include Ramesh Pathy Manian; and Lakshmi Priya D.

The application for the patent was published on October 02, 2026, under issue no. 40/2026.

Abstract: ABSTRACT The present invention provides a three-dimensional bioprinted controlled drug delivery platform comprising pentoxifylline (PTX)-loaded liposomes and NIH 3T3 fibroblasts encapsulated within a GelMA hydrogel. The bioink comprises methacrylated gelatin, a biocompatible photoinitiator, PTX-loaded liposomes, and NIH...